Pre-clinical reports from our group at Johns Hopkins Medicine and others also showed that deregulation of IL-6 can occur during some severe pathological instances like autoimmune disorders, cardiovascular disorders, and different types of cancer [31,32,33,34]. The gene discussed is IL6; the disease is cancer.